Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.
- DOI
- 10.1111/j.1538-7836.2008.03054.x
- Published
- 2008 Aug
- Container
- Journal of thrombosis and haemostasis : JTH
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/j.1538-7836.2008.03054.x,
title = {Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.},
author = {Botticelli Investigators, Writing Committe and Buller H and Deitchman D and Prins M and Segers A},
year = {2008},
journal = {Journal of thrombosis and haemostasis : JTH},
doi = {10.1111/j.1538-7836.2008.03054.x},
url = {https://doi.org/10.1111/j.1538-7836.2008.03054.x}
}RIS
TY - JOUR TI - Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. AU - Botticelli Investigators, Writing Committe AU - Buller H AU - Deitchman D AU - Prins M AU - Segers A PY - 2008 JO - Journal of thrombosis and haemostasis : JTH DO - 10.1111/j.1538-7836.2008.03054.x UR - https://doi.org/10.1111/j.1538-7836.2008.03054.x ER -
APA
Committe, B. I. W., H, B., D, D., M, P., & A, S. (2008). Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.. Journal of thrombosis and haemostasis : JTH. https://doi.org/10.1111/j.1538-7836.2008.03054.x
Source records
- pubmed · retrieved 2026-09-26T03:57:07.956Z